21-23 June 2010
London, UK

In the current economic climate, there is more pressure than ever before to ensure that drug candidates are developed into target effective and profit-making drugs in the most efficient manner. With this in mind, pharmaceutical companies are concentrating on streamlining their formulation and development strategies to ensure that optimal solubility and bioavailablity is achieved in the most cost-effective way. To realise this, companies are implementing a tailored compliment of new technologies, simulations, in silico approaches and analytics in order to optimise efficiency and in turn, maximise commercial return.

Consequently, Pharma IQ’s 6th Annual Improving Solubility conference taking place in London on 22nd-23rd June with pre-conference workshops on 21st June will explore the newest solubility enhancement technologies, and the best practice strategies of their implementation to ensure efficiency from discovery to preclinical development.

New for 2010!

Due to popular demand, Pharma IQ is delighted to announce that in addition to sessions tackling the issues of solubility in the pharmaceutical sector, there will also be afternoon streams on each day of the conference dedicated to addressing the problems and enhancement of solubility for biotechnology and biopharmaceutical products.